Global in vitro diagnostics (IVD) market will reach $148,393.3 million by 2031, growing by 6.3% annually over 2021-2031, driven by the increasing prevalence of chronic diseases along with the growing geriatric population, burgeoning demand for automation in diagnostics, the rising development of condition-specific treatment and booming awareness regarding personalized medicines, emergence of minimally invasive and non-invasive diagnostics tools & techniques, the rising healthcare expenditure, and rise in the demand for POC testing.
Highlighted with 84 tables and 96 figures, this 194-page report "Global In Vitro Diagnostics (IVD) Market 2021-2031 by Product (Instruments & Devices, Reagents & Kits, Software & Services), Technology (Clinical Chemistry, Molecular Diagnostics, Immuno Diagnostics), Sample Type (Blood, Mucus, Urine), Application (Infectious Diseases, Diabetes, Cancer/Oncology), End User (Diagnostic Labs, Hospitals and Clinics, Homecare, POC), and Region: Trend Forecast and Growth Opportunity" is based on a comprehensive research of the entire global in vitro diagnostics (IVD) market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter's Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify global in vitro diagnostics (IVD) market in every aspect of the classification from perspectives of Product, Technology, Sample Type, Application, End User, and Region.
Based on Product, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Instruments & Devices
o Disposable IVD Devices
o Reusable IVD Devices
• Reagents & Kits
• Software & Services
Based on Technology, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Clinical Chemistry
• Molecular Diagnostics
• Immuno Diagnostics
• Hematology
• Tissue Diagnostics
• Microbiology
• Coagulation and Hemostasis
• Urinalysis
• Other Technologies
By Sample Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Blood
• Mucus
• Urine
• Other Sample Types
By Application, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Infectious Diseases
• Diabetes
• Cancer/Oncology
• Cardiology
• Autoimmune Disease
• Nephrology
• Drug Testing
• HIV/AIDS
• Other Applications
By End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Diagnostic Laboratories
• Hospitals and Clinics
• Homecare Settings
• Point-of-Care (POC) Settings
• Other End Users
Geographically, the following regions together with the listed national/local markets are fully investigated:
• North America (U.S., Canada, and Mexico)
• Europe (Germany, UK, France, Spain, Italy, Netherlands, Rest of Europe; Rest of Europe is further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
• South America (Brazil, Chile, Argentina, Rest of South America)
• MEA (UAE，Saudi Arabia, South Africa and Rest of MEA)
For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by country and split of each national market by Product, Application and End User over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Abbott Laboratories, Inc.
Agilent Technologies, Inc.
Arkray Inc.
Becton, Dickinson and Company
Biomerieux SA
Bio-Rad Laboratories Inc.
Danaher Corporation
DiaSorin SpA (Luminex Corporation)
Epic Systems Corporation
F. Hoffmann-La Roche Ltd.
Genpact Limited
Grifols SA
IBM Corporation
Mckesson Corporation
Ortho Clinical Diagnostics Inc.
Qiagen NV
Quest Diagnostics Inc.
Quidel Corporation
Roche Diagnostics
Siemens Healthineers
Sysmex Corporation
Thermo Fisher Scientific Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 10
1.1 Industry Definition and Research Scope 10
1.1.1 Industry Definition 10
1.1.2 Research Scope 11
1.2 Research Methodology 14
1.2.1 Overview of Market Research Methodology 14
1.2.2 Market Assumption 15
1.2.3 Secondary Data 15
1.2.4 Primary Data 15
1.2.5 Data Filtration and Model Design 16
1.2.6 Market Size/Share Estimation 17
1.2.7 Research Limitations 18
1.3 Executive Summary 19
2 Market Overview and Dynamics 22
2.1 Market Size and Forecast 22
2.1.1 Impact of COVID-19 on World Economy 23
2.1.2 Impact of COVID-19 on the Market 27
2.2 Major Growth Drivers 29
2.3 Market Restraints and Challenges 35
2.4 Emerging Opportunities and Market Trends 38
2.5 Porter's Fiver Forces Analysis 42
3 Segmentation of Global Market by Product 46
3.1 Market Overview by Product 46
3.2 Instruments & Devices 48
3.2.1 Disposable IVD Devices 49
3.2.2 Reusable IVD Devices 50
3.3 Reagents & Kits 51
3.4 Software & Services 52
4 Segmentation of Global Market by Technology 53
4.1 Market Overview by Technology 53
4.2 Clinical Chemistry 55
4.3 Molecular Diagnostics 56
4.4 Immuno Diagnostics 57
4.5 Hematology 58
4.6 Tissue Diagnostics 59
4.7 Microbiology 60
4.8 Coagulation and Hemostasis 61
4.9 Urinalysis 62
4.10 Other Technologies 63
5 Segmentation of Global Market by Sample Type 64
5.1 Market Overview by Sample Type 64
5.2 Blood 66
5.3 Mucus 67
5.4 Urine 68
5.5 Other Sample Types 69
6 Segmentation of Global Market by Application 70
6.1 Market Overview by Application 70
6.2 Infectious Diseases 72
6.3 Diabetes 82
6.4 Cancer/Oncology 83
6.5 Cardiology 84
6.6 Autoimmune Disease 85
6.7 Nephrology 86
6.8 Drug Testing 87
6.9 HIV/AIDS 88
6.10 Other Applications 89
7 Segmentation of Global Market by End User 90
7.1 Market Overview by End User 90
7.2 Diagnostic Laboratories 92
7.3 Hospitals and Clinics 93
7.4 Homecare Settings 94
7.5 Point-of-Care (POC) Settings 95
7.6 Other End Users 96
8 Segmentation of Global Market by Region 97
8.1 Geographic Market Overview 2021-2031 97
8.2 North America Market 2021-2031 by Country 101
8.2.1 Overview of North America Market 101
8.2.2 U.S. 105
8.2.3 Canada 108
8.2.4 Mexico 110
8.3 European Market 2021-2031 by Country 112
8.3.1 Overview of European Market 112
8.3.2 Germany 116
8.3.3 U.K. 118
8.3.4 France 120
8.3.5 Spain 122
8.3.6 Italy 124
8.3.7 Netherlands 126
8.3.8 Rest of European Market 128
8.4 Asia-Pacific Market 2021-2031 by Country 130
8.4.1 Overview of Asia-Pacific Market 130
8.4.2 Japan 134
8.4.3 China 137
8.4.4 Australia 139
8.4.5 India 141
8.4.6 South Korea 143
8.4.7 Rest of APAC Region 145
8.5 South America Market 2021-2031 by Country 147
8.5.1 Argentina 150
8.5.2 Brazil 152
8.5.3 Chile 154
8.5.4 Rest of South America Market 156
8.6 MEA Market 2021-2031 by Country 157
8.6.1 UAE 160
8.6.2 Saudi Arabia 162
8.6.3 South Africa 164
8.6.4 Other National Markets 166
9 Competitive Landscape 167
9.1 Overview of Key Vendors 167
9.2 New Product Launch, Partnership, Investment, and M&A 170
9.3 Company Profiles 171
Abbott Laboratories, Inc. 171
Agilent Technologies, Inc. 173
Arkray Inc. 174
Becton, Dickinson and Company 175
Biomerieux SA 176
Bio-Rad Laboratories Inc. 177
Danaher Corporation 178
DiaSorin SpA (Luminex Corporation) 179
Epic Systems Corporation 180
F. Hoffmann-La Roche Ltd. 181
Genpact Limited 182
Grifols SA 183
IBM Corporation 184
Mckesson Corporation 185
Ortho Clinical Diagnostics Inc. 186
Qiagen NV 187
Quest Diagnostics Inc. 188
Quidel Corporation 189
Roche Diagnostics 190
Siemens Healthineers 191
Sysmex Corporation 192
Thermo Fisher Scientific Inc. 193
RELATED REPORTS 194
Market Overview
The Asia Pacific Nuclear Medicine Market is poised for significant growth from 2024 to 2034, driven by advancements in nuclear imaging technologies, increased application in various medical fields, and rising healthcare investments across the region. The market is expect...
Market Overview
The Europe Nuclear Medicine Market is expected to witness substantial growth from 2024 to 2034, driven by advancements in nuclear imaging technology, increasing demand for early and accurate diagnosis, and the growing prevalence of chronic diseases such as cancer and car...
Market Overview
The North America Nuclear Medicine Market is poised for substantial growth between 2024 and 2034, driven by advancements in diagnostic imaging and therapeutic applications, rising prevalence of chronic diseases, and increasing adoption of nuclear medicine techniques. The...
Market Overview
The Global Nuclear Medicine Market is projected to experience significant growth from 2024 to 2034, driven by technological advancements in diagnostic imaging and the increasing demand for targeted radiopharmaceutical therapies. Valued at USD XX.XX billion in 2024, the m...
The In Vitro Drug Permeation Testing (IVPT) Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landsc...
The In Vitro Antibody Production Service Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape...
The In Vitro Release Testing Solutions Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, ...
The In Vitro Dissolution Testing Solutions Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landsca...
The In Vitro Dissolution Testing Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufa...
The In Vitro Diagnostics Analyzers Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manu...